You are here

  • Home
  • Archive
  • Volume 26, Issue Suppl 1
  • 5PSQ-083 Development and validation of quality indicators for benzodiazepine use in general and mental health hospitals: shortcomings of available reimbursement data

Article info

Article menu

Download PDFPDF

Section 5: Patient Safety and Quality Assurance
5PSQ-083 Development and validation of quality indicators for benzodiazepine use in general and mental health hospitals: shortcomings of available reimbursement data
Free

Authors

Citation

Pijpen N, Desplenter F, Cosemans P, et al
5PSQ-083 Development and validation of quality indicators for benzodiazepine use in general and mental health hospitals: shortcomings of available reimbursement data
European Journal of Hospital Pharmacy 2019;26:A239-A240.

Publication history

  • First published March 11, 2019.
Online issue publication 
May 12, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions